Skip to main content

Table 2 Clinical and Histopathological Characteristics

From: Pharmacokinetic parameters and radiomics model based on dynamic contrast enhanced MRI for the preoperative prediction of sentinel lymph node metastasis in breast cancer

 

Patients with positive SLN (n = 78)

Patients with negative SLN(n = 86)

p value

Age (mean ± SD)

55.71 ± 8.6

54.40 ± 11.1

0.483

Tumor size (mean ± SD)

2.24 ± 1.0

2.21 ± 1.2

0.698

Histological grade

  

0.171

 I

4 (5.15%)

25 (11.6%)

 

 II

33 (42.3%)

41 (47.7%)

 

 III

41 (52.6%)

20 (40.7%)

 

Molecular subtype

  

0.220

 Luminal A

30 (38.5%)

31 (36%)

 

 Luminal B

37 (47.4%)

33 (38.4%)

 

HER2 over-expression

6 (7.7%)

8 (9.3%)

 

Basal-like

5 (6.4%)

14 (16.3%)

 
Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us